The US Food and Drug Administration (FDA) has ordered changes to the labeling for benzodiazepines, requiring them to include information on the risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions.
In patients with comorbid chronic pain and substance use disorders, developing protocols for continuing opioid therapy are key for patient safety, W. Clay Jackson, MD, and Arwen Podesta, MD, DFASAM, DFAPA, ABIHM, told Psych Congress 2020 attendees.
BLOG: Psychedelic-assisted therapies, once consigned to the fringes of psychiatric practice, are exploding into the mainstream of psychiatry and will take center stage at a Psych Congress preconference.
Although the situation has improved, a quarter of general hospital admissions involving people with severe mental illness in 2017 failed to record a psychiatric condition, according to a study published online in PLOS Medicine.
Fewer than 10% of patients diagnosed with major depressive disorder or another type of depression in a primary care setting received a referral to a mental health specialist within 3 years, according to a poster presented at Psych Congress 2020.
Physician assistants (PAs) may offer an effective way to ensure patients have access to quality mental health care despite the projected shortage of psychiatrists in the near future, according to a poster presented at Psych Congress 2020.
Bernhard T. Baune, PhD, MD, head of the Department of Mental Health at the University of Münster, Germany, discusses the occurrence of cognitive deficits in patients with various psychiatric disorders.